| Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology F Malavasi, S Deaglio, A Funaro, E Ferrero, AL Horenstein, E Ortolan, ... Physiological reviews 88 (3), 841-886, 2008 | 1038 | 2008 |
| Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ... Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011 | 489 | 2011 |
| The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ... Journal of Experimental Medicine 209 (9), 1537-1551, 2012 | 423 | 2012 |
| Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ... Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012 | 395 | 2012 |
| CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival S Deaglio, T Vaisitti, L Bergui, L Bonello, AL Horenstein, L Tamagnone, ... Blood 105 (8), 3042-3050, 2005 | 281 | 2005 |
| CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential S Deaglio, T Vaisitti, S Aydin, L Bergui, G D'Arena, L Bonello, P Omedé, ... Blood, The Journal of the American Society of Hematology 110 (12), 4012-4021, 2007 | 241 | 2007 |
| Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma D Rossi, S Deaglio, D Dominguez-Sola, S Rasi, T Vaisitti, C Agostinelli, ... Blood, The Journal of the American Society of Hematology 118 (18), 4930-4934, 2011 | 236 | 2011 |
| Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network V Audrito, T Vaisitti, D Rossi, D Gottardi, G D'Arena, L Laurenti, G Gaidano, ... Cancer research 71 (13), 4473-4483, 2011 | 225 | 2011 |
| In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia S Deaglio, T Vaisitti, S Aydin, E Ferrero, F Malavasi Blood 108 (4), 1135-1144, 2006 | 189 | 2006 |
| Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia V Audrito, S Serra, D Brusa, F Mazzola, F Arruga, T Vaisitti, M Coscia, ... Blood, The Journal of the American Society of Hematology 125 (1), 111-123, 2015 | 186 | 2015 |
| CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells L Frasca, G Fedele, S Deaglio, C Capuano, R Palazzo, T Vaisitti, ... Blood 107 (6), 2392-2399, 2006 | 182 | 2006 |
| CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death S Serra, AL Horenstein, T Vaisitti, D Brusa, D Rossi, L Laurenti, G D'Arena, ... Blood, The Journal of the American Society of Hematology 118 (23), 6141-6152, 2011 | 161 | 2011 |
| Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia F Arruga, B Gizdic, S Serra, T Vaisitti, C Ciardullo, M Coscia, L Laurenti, ... Leukemia 28 (5), 1060-1070, 2014 | 145 | 2014 |
| CD38/CD19: a lipid raft–dependent signaling complex in human B cells S Deaglio, T Vaisitti, R Billington, L Bergui, P Omede', AA Genazzani, ... Blood, The Journal of the American Society of Hematology 109 (12), 5390-5398, 2007 | 144 | 2007 |
| CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells T Vaisitti, S Aydin, D Rossi, F Cottino, L Bergui, G D'arena, L Bonello, ... Leukemia 24 (5), 958-969, 2010 | 132 | 2010 |
| CD38 at the junction between prognostic marker and therapeutic target S Deaglio, S Aydin, T Vaisitti, L Bergui, F Malavasi Trends in molecular medicine 14 (5), 210-218, 2008 | 129 | 2008 |
| CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity F Malavasi, S Deaglio, E Ferrero, A Funaro, J Sancho, CM Ausiello, ... Molecular medicine 12, 334-341, 2006 | 120 | 2006 |
| CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells S Deaglio, S Aydin, MM Grand, T Vaisitti, L Bergui, G D’Arena, G Chiorino, ... Molecular medicine 16, 87-91, 2010 | 113 | 2010 |
| The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells A Zucchetto, T Vaisitti, D Benedetti, E Tissino, V Bertagnolo, D Rossi, ... Leukemia 26 (6), 1301-1312, 2012 | 111 | 2012 |
| Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions F Arruga, BB Gyau, A Iannello, N Vitale, T Vaisitti, S Deaglio International journal of molecular sciences 21 (5), 1825, 2020 | 105 | 2020 |
